Aicaigou LogoAicaigou LogoB2B WikiIndustrial Encyclopedia

ANA-12

Updated: 2026-07-31

Overview

ANA-12 is a synthetic small-molecule antagonist of the tropomyosin receptor kinase B (TrkB), the primary receptor for brain-derived neurotrophic factor (BDNF). Developed for research purposes, it selectively blocks BDNF/TrkB signaling without affecting other Trk receptors (TrkA or TrkC). This specificity makes it a critical tool in neuropharmacology and molecular neuroscience. First reported in 2012, ANA-12 has been widely adopted in studies investigating neuroplasticity, mood disorders, and neurodegenerative conditions like Alzheimer's disease. Its reversible binding mechanism allows for precise temporal control in experimental settings, distinguishing it from genetic knockout models.

Physical and Chemical Properties

凯基特/KJTDQ KHP-03DA 耐温接近开关传感器-40℃~230℃钢铁 冶金南京凯基特电气有限公司

ANA-12 appears as a white to off-white crystalline powder with a molecular weight of 377.36 g/mol. It demonstrates optimal solubility in dimethyl sulfoxide (DMSO) and methanol, often prepared as stock solutions for in vitro or in vivo applications. The compound exhibits stability when stored at -20°C in anhydrous conditions but degrades upon prolonged exposure to light or moisture. Its chemical structure includes a trifluoromethyl group and aromatic rings, contributing to its hydrophobic character and membrane permeability. These properties enable effective blood-brain barrier penetration in animal studies, though solubility limitations may require vehicle optimization for specific experimental protocols.

商家经验真实案例 · 安全可信
质粒提取:试剂盒操作全攻略
本文详细介绍质粒提取试剂盒的使用步骤,包括准备工作、操作流程及注意事项,帮助科研新手快速掌握质粒提取技巧,提高实验效率。

Main Applications

In neuroscience research, ANA-12 serves three primary functions: (1) Elucidating BDNF/TrkB signaling pathways in synaptic plasticity and memory formation, (2) Modeling depression-like behaviors in rodents by inhibiting neurotrophic support, and (3) Investigating therapeutic strategies for neurodegenerative diseases where BDNF dysregulation occurs. Recent studies employ ANA-12 to explore its effects on pain perception, addiction mechanisms, and neurodevelopmental disorders. Pharmaceutical researchers also use it to validate TrkB-targeting drug candidates by establishing baseline inhibition effects. Dosages typically range from 0.5-1.0 mg/kg in rodent models, though concentration must be empirically determined for each experimental system.

Safety and Storage

ANA-12(ANA12) TrkB/BDNF受体拮抗剂 CAS 219766-25-3翌圣生物科技(上海)股份有限公司

As a research chemical, ANA-12 requires handling with appropriate personal protective equipment (PPE) including nitrile gloves, lab coats, and eye protection. While acute toxicity data remains limited, it should be treated as potentially hazardous due to its bioactive properties. Avoid generating dust or aerosols during preparation. For long-term stability, store lyophilized powder in sealed vials with desiccant at -20°C, protected from light. Prepared solutions in DMSO remain stable for approximately 2 weeks when stored at -80°C in aliquots. Never freeze-thaw repeatedly. Dispose of waste according to institutional regulations for organic compounds.

商家经验真实案例 · 安全可信
氯甲环酸解析
本文深入探讨氯甲环酸的特性、应用领域及注意事项,帮助读者全面了解这一化学物质在工业及医疗中的重要作用。

B2B Procurement Guide

When sourcing ANA-12 for laboratory use, prioritize suppliers specializing in neuroscience research chemicals. Key procurement criteria include: (1) Certificate of Analysis confirming ≥98% purity via HPLC, (2) Batch-specific NMR and mass spectrometry reports, (3) Proper packaging with temperature-controlled shipping options. Research institutions commonly purchase 5-25mg quantities, with prices ranging from $50-$200 depending on purity and supplier reputation. Consider vendors offering custom synthesis for large-scale studies. Always verify CAS number 1092629-42-8 to avoid counterfeit products. Lead times vary from 1-4 weeks for specialty chemicals, so plan experiments accordingly.

Related Manufacturers